Z. A. Ameen and S. H. Ali, “Effects of Aldosterone, Osteoprotegerin and Fibroblast Growth Factor-23 and Some Biochemical Markers in Chronic Kidney Disease Patients (Stage II-IV) among Patients with or without Cardiovascular Events”, Iraqi Journal of Pharmaceutical Sciences , vol. 27, no. 2, pp. 150–158, Dec. 2018, doi: 10.31351/vol27iss2pp150-158.